Physician profile
Ellen Stapleton
NPI 1962078444
$557.22
in general payments reported to CMS, 2019-2025
16 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.00 · 2022: $93.24 · 2023: $88.16 · 2024: $95.28 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $109.78 | 2023-2025 | Nexplanon |
| Abbvie INC. | $85.22 | 2021-2025 | |
| Stryker Corporation | $79.39 | 2022 | |
| Sun Pharmaceutical Industries INC. | $54.10 | 2024-2025 | |
| Lilly USA, LLC | $32.35 | 2025 | Taltz, Ebglyss |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.44 | 2025 | Spevigo |
| Janssen Biotech, INC. | $20.80 | 2025 | Tremfya |
| Mallinckrodt Hospital Products INC. | $20.25 | 2025 | Acthar |
| Mayne Pharma Commercial LLC | $19.49 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.38 | 2024 | Jublia |
| Incyte Corporation | $17.82 | 2025 | Opzelura |
| Lnhc, INC | $17.68 | 2025 | Zelsuvmi |
| Exeltis, USA INC. | $16.87 | 2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $15.39 | 2023 | |
| Shield Therapeutics INC | $14.41 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.